Cargando…
IONA test for first‐trimester detection of trisomies 21, 18 and 13
OBJECTIVE: To assess the potential performance of screening for fetal trisomies 21, 18 and 13 by cell‐free DNA (cfDNA) analysis of maternal blood using the IONA® test. METHODS: This was a nested case–control study of cfDNA analysis of maternal plasma using the IONA test. Samples were obtained at 11–...
Autores principales: | Poon, L. C., Dumidrascu‐Diris, D., Francisco, C., Fantasia, I., Nicolaides, K. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064725/ https://www.ncbi.nlm.nih.gov/pubmed/26387684 http://dx.doi.org/10.1002/uog.15749 |
Ejemplares similares
-
Clinical evaluation of the IONA test: a non‐invasive prenatal screening test for trisomies 21, 18 and 13
por: Papageorghiou, A. T., et al.
Publicado: (2015) -
Application of an individualized nomogram in first‐trimester screening for trisomy 21
por: Sun, Y., et al.
Publicado: (2021) -
Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
por: Weiner, Carl P., et al.
Publicado: (2022) -
Detection of trisomies 13, 18 and 21 using non-invasive prenatal testing
por: Qiang, Rong, et al.
Publicado: (2017) -
An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019)